Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

NuVasive Q1 Adj. EPS $0.47 Beats $0.43 Estimate, Sales $307.71M Beat $298.22M Estimate

Author: Michael Horton | May 10, 2023 04:08pm
NuVasive (NASDAQ:NUVA) reported quarterly earnings of $0.47 per share which beat the analyst consensus estimate of $0.43 by 9.3 percent. This is a 12.96 percent decrease over earnings of $0.54 per share from the same period last year. The company reported quarterly sales of $307.71 million which beat the analyst consensus estimate of $298.22 million by 3.18 percent. This is a 5.83 percent increase over sales of $290.76 million the same period last year.

Posted In: NUVA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist